Since joining Juvena Therapeutics, Tejaswini Ganapathi has worked on the development of AI models that power Juvena’s protein discovery for targeted in vitro screening, and will be exploring the application of AI to other aspects of the company’s drug pipeline as well.
Tejaswini has extensive experience in machine learning algorithm development both in research and production and towards building end to end ML systems. Her industry experience spans various domains such as healthcare, medical imaging, finance and wireless networks. She has been an early employee at 2 startups with successful exits and holds ~10 patents. She pursued her graduate studies at University of Toronto and University of Texas at Austin, both specializing in machine learning.
Outside of AI and work, Tejaswini is a RYT200 Yoga instructor, is trained in Indian Classical music and tries to contribute her time to animal rescues.
Learn more about Tejaswini